Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 361 to 372 of 372 entries
Sorted by: Best Match Show Resources per page
Transparency in out-of-hospital cardiac arrest resuscitation: decision-making when patients are in the grey area between treatment and futility.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine

Milling L, Lassen AT, Mikkelsen S.
PMID: 34560702
Eur J Emerg Med. 2021 Dec 01;28(6):414-415. doi: 10.1097/MEJ.0000000000000880.

No abstract available.

Cite
Milling L, Lassen AT, Mikkelsen S. Transparency in out-of-hospital cardiac arrest resuscitation: decision-making when patients are in the grey area between treatment and futility. Eur J Emerg Med. 2021;28(6):414-415doi: 10.1097/MEJ.0000000000000880.
Milling, L., Lassen, A. T., & Mikkelsen, S. (2021). Transparency in out-of-hospital cardiac arrest resuscitation: decision-making when patients are in the grey area between treatment and futility. European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 28(6), 414-415. https://doi.org/10.1097/MEJ.0000000000000880
Milling, Louise, et al. "Transparency in out-of-hospital cardiac arrest resuscitation: decision-making when patients are in the grey area between treatment and futility." European journal of emergency medicine : official journal of the European Society for Emergency Medicine vol. 28,6 (2021): 414-415. doi: https://doi.org/10.1097/MEJ.0000000000000880
Milling L, Lassen AT, Mikkelsen S. Transparency in out-of-hospital cardiac arrest resuscitation: decision-making when patients are in the grey area between treatment and futility. Eur J Emerg Med. 2021 Dec 01;28(6):414-415. doi: 10.1097/MEJ.0000000000000880. PMID: 34560702.
Copy Download .nbib Format: NLM
Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors.

Critical care explorations

Sevin CM, Boehm LM, Hibbert E, Bastin AJ, Jackson JC, Meyer J, Quasim T, Bakhru RN, Montgomery-Yates A, Slack A, Still M, Netzer G, Mikkelsen ME, Iwashyna TJ, Haines KJ, McPeake J.
PMID: 34079948
Crit Care Explor. 2021 May 12;3(5):e0420. doi: 10.1097/CCE.0000000000000420. eCollection 2021 May.

OBJECTIVES: To understand the unmet needs of caregivers of ICU survivors, how they accessed support post ICU, and the key components of beneficial ICU recovery support systems as identified from a caregiver perspective.DESIGN: International, qualitative study.SUBJECTS: We conducted 20...

Cite
Sevin CM, Boehm LM, Hibbert E, et al. Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors. Crit Care Explor. 2021;3(5):e0420doi: 10.1097/CCE.0000000000000420.
Sevin, C. M., Boehm, L. M., Hibbert, E., Bastin, A. J., Jackson, J. C., Meyer, J., Quasim, T., Bakhru, R. N., Montgomery-Yates, A., Slack, A., Still, M., Netzer, G., Mikkelsen, M. E., Iwashyna, T. J., Haines, K. J., & McPeake, J. (2021). Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors. Critical care explorations, 3(5), e0420. https://doi.org/10.1097/CCE.0000000000000420
Sevin, Carla M, et al. "Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors." Critical care explorations vol. 3,5 (2021): e0420. doi: https://doi.org/10.1097/CCE.0000000000000420
Sevin CM, Boehm LM, Hibbert E, Bastin AJ, Jackson JC, Meyer J, Quasim T, Bakhru RN, Montgomery-Yates A, Slack A, Still M, Netzer G, Mikkelsen ME, Iwashyna TJ, Haines KJ, McPeake J. Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors. Crit Care Explor. 2021 May 12;3(5):e0420. doi: 10.1097/CCE.0000000000000420. eCollection 2021 May. PMID: 34079948; PMCID: PMC8162533.
Copy Download .nbib Format: NLM
Mercury and neurochemical biomarkers in multiple brain regions of five Arctic marine mammals.

Neurotoxicology

Desforges JP, Mikkelsen B, Dam M, Rigét F, Sveegaard S, Sonne C, Dietz R, Basu N.
PMID: 33774067
Neurotoxicology. 2021 May;84:136-145. doi: 10.1016/j.neuro.2021.03.006. Epub 2021 Mar 24.

Mercury is a neurotoxic chemical that represents one of the greatest pollution threats to Arctic ecosystem health. Evaluating the direct neurotoxic effects of mercury in free ranging wildlife is challenging, necessitating the use of neurochemical biomarkers to assess potential...

Cite
Desforges JP, Mikkelsen B, Dam M, et al. Mercury and neurochemical biomarkers in multiple brain regions of five Arctic marine mammals. Neurotoxicology. 2021;84:136-145doi: 10.1016/j.neuro.2021.03.006.
Desforges, J. P., Mikkelsen, B., Dam, M., Rigét, F., Sveegaard, S., Sonne, C., Dietz, R., & Basu, N. (2021). Mercury and neurochemical biomarkers in multiple brain regions of five Arctic marine mammals. Neurotoxicology, 84136-145. https://doi.org/10.1016/j.neuro.2021.03.006
Desforges, J P, et al. "Mercury and neurochemical biomarkers in multiple brain regions of five Arctic marine mammals." Neurotoxicology vol. 84 (2021): 136-145. doi: https://doi.org/10.1016/j.neuro.2021.03.006
Desforges JP, Mikkelsen B, Dam M, Rigét F, Sveegaard S, Sonne C, Dietz R, Basu N. Mercury and neurochemical biomarkers in multiple brain regions of five Arctic marine mammals. Neurotoxicology. 2021 May;84:136-145. doi: 10.1016/j.neuro.2021.03.006. Epub 2021 Mar 24. PMID: 33774067.
Copy Download .nbib Format: NLM
Radiomics for precision medicine in glioblastoma.

Journal of neuro-oncology

Aftab K, Aamir FB, Mallick S, Mubarak F, Pope WB, Mikkelsen T, Rock JP, Enam SA.
PMID: 35020109
J Neurooncol. 2022 Jan 12; doi: 10.1007/s11060-021-03933-1. Epub 2022 Jan 12.

INTRODUCTION: Being the most common primary brain tumor, glioblastoma presents as an extremely challenging malignancy to treat with dismal outcomes despite treatment. Varying molecular epidemiology of glioblastoma between patients and intra-tumoral heterogeneity explains the failure of current one-size-fits-all treatment...

Cite
Aftab K, Aamir FB, Mallick S, et al. Radiomics for precision medicine in glioblastoma. J Neurooncol. 2022;doi: 10.1007/s11060-021-03933-1.
Aftab, K., Aamir, F. B., Mallick, S., Mubarak, F., Pope, W. B., Mikkelsen, T., Rock, J. P., & Enam, S. A. (2022). Radiomics for precision medicine in glioblastoma. Journal of neuro-oncology, . https://doi.org/10.1007/s11060-021-03933-1
Aftab, Kiran, et al. "Radiomics for precision medicine in glioblastoma." Journal of neuro-oncology vol. (2022). doi: https://doi.org/10.1007/s11060-021-03933-1
Aftab K, Aamir FB, Mallick S, Mubarak F, Pope WB, Mikkelsen T, Rock JP, Enam SA. Radiomics for precision medicine in glioblastoma. J Neurooncol. 2022 Jan 12; doi: 10.1007/s11060-021-03933-1. Epub 2022 Jan 12. PMID: 35020109.
Copy Download .nbib Format: NLM
Regional Differences in Gamma-Aminobutyric Acid and Glutamate Concentrations in the Healthy Newborn Brain.

AJNR. American journal of neuroradiology

Basu SK, Pradhan S, Barnett SD, Mikkelsen M, Kapse KJ, Murnick J, Quistorff JL, Lopez CA, du Plessis AJ, Limperopoulos C.
PMID: 34764083
AJNR Am J Neuroradiol. 2022 Jan;43(1):125-131. doi: 10.3174/ajnr.A7336. Epub 2021 Nov 11.

BACKGROUND AND PURPOSE: Gamma-aminobutyric acid and glutamate system disruptions may underlie neonatal brain injury. However, in vivo investigations are challenged by the need for special MATERIALS AND METHODS: We prospectively enrolled healthy neonates and acquired Mescher-Garwood point-resolved spectroscopy spectra...

Cite
Basu SK, Pradhan S, Barnett SD, et al. Regional Differences in Gamma-Aminobutyric Acid and Glutamate Concentrations in the Healthy Newborn Brain. AJNR Am J Neuroradiol. 2021;43(1):125-131doi: 10.3174/ajnr.A7336.
Basu, S. K., Pradhan, S., Barnett, S. D., Mikkelsen, M., Kapse, K. J., Murnick, J., Quistorff, J. L., Lopez, C. A., du Plessis, A. J., & Limperopoulos, C. (2022). Regional Differences in Gamma-Aminobutyric Acid and Glutamate Concentrations in the Healthy Newborn Brain. AJNR. American journal of neuroradiology, 43(1), 125-131. https://doi.org/10.3174/ajnr.A7336
Basu, S K, et al. "Regional Differences in Gamma-Aminobutyric Acid and Glutamate Concentrations in the Healthy Newborn Brain." AJNR. American journal of neuroradiology vol. 43,1 (2022): 125-131. doi: https://doi.org/10.3174/ajnr.A7336
Basu SK, Pradhan S, Barnett SD, Mikkelsen M, Kapse KJ, Murnick J, Quistorff JL, Lopez CA, du Plessis AJ, Limperopoulos C. Regional Differences in Gamma-Aminobutyric Acid and Glutamate Concentrations in the Healthy Newborn Brain. AJNR Am J Neuroradiol. 2022 Jan;43(1):125-131. doi: 10.3174/ajnr.A7336. Epub 2021 Nov 11. PMID: 34764083.
Copy Download .nbib Format: NLM
Testing the limits: the diagnostic accuracy of reference change values.

Scandinavian journal of clinical and laboratory investigation

Åsberg A, Lian IA, Odsæter IH, Mikkelsen G.
PMID: 33787419
Scand J Clin Lab Invest. 2021 Jul;81(4):318-323. doi: 10.1080/00365513.2021.1904517. Epub 2021 Mar 31.

Reference change values (RCVs) are used by the physician to judge whether a change in analyte concentration from one sample to the next may represent a clinically significant change. Published RCVs are usually given as fixed percentages of the...

Cite
Åsberg A, Lian IA, Odsæter IH, et al. Testing the limits: the diagnostic accuracy of reference change values. Scand J Clin Lab Invest. 2021;81(4):318-323doi: 10.1080/00365513.2021.1904517.
Åsberg, A., Lian, I. A., Odsæter, I. H., & Mikkelsen, G. (2021). Testing the limits: the diagnostic accuracy of reference change values. Scandinavian journal of clinical and laboratory investigation, 81(4), 318-323. https://doi.org/10.1080/00365513.2021.1904517
Åsberg, Arne, et al. "Testing the limits: the diagnostic accuracy of reference change values." Scandinavian journal of clinical and laboratory investigation vol. 81,4 (2021): 318-323. doi: https://doi.org/10.1080/00365513.2021.1904517
Åsberg A, Lian IA, Odsæter IH, Mikkelsen G. Testing the limits: the diagnostic accuracy of reference change values. Scand J Clin Lab Invest. 2021 Jul;81(4):318-323. doi: 10.1080/00365513.2021.1904517. Epub 2021 Mar 31. PMID: 33787419.
Copy Download .nbib Format: NLM
The macromolecular MR spectrum does not change with healthy aging.

Magnetic resonance in medicine

Hui SCN, Gong T, Zöllner HJ, Song Y, Murali-Manohar S, Oeltzschner G, Mikkelsen M, Tapper S, Chen Y, Saleh MG, Porges EC, Chen W, Wang G, Edden RAE.
PMID: 34841564
Magn Reson Med. 2021 Nov 28; doi: 10.1002/mrm.29093. Epub 2021 Nov 28.

PURPOSE: To acquire the mobile macromolecule (MM) spectrum from healthy participants, and to investigate changes in the signals with age and sex.METHODS: 102 volunteers (49 M/53 F) between 20 and 69 years were recruited for in vivo data acquisition...

Cite
Hui SCN, Gong T, Zöllner HJ, et al. The macromolecular MR spectrum does not change with healthy aging. Magn Reson Med. 2021;doi: 10.1002/mrm.29093.
Hui, S. C. N., Gong, T., Zöllner, H. J., Song, Y., Murali-Manohar, S., Oeltzschner, G., Mikkelsen, M., Tapper, S., Chen, Y., Saleh, M. G., Porges, E. C., Chen, W., Wang, G., & Edden, R. A. E. (2021). The macromolecular MR spectrum does not change with healthy aging. Magnetic resonance in medicine, . https://doi.org/10.1002/mrm.29093
Hui, Steve C N, et al. "The macromolecular MR spectrum does not change with healthy aging." Magnetic resonance in medicine vol. (2021). doi: https://doi.org/10.1002/mrm.29093
Hui SCN, Gong T, Zöllner HJ, Song Y, Murali-Manohar S, Oeltzschner G, Mikkelsen M, Tapper S, Chen Y, Saleh MG, Porges EC, Chen W, Wang G, Edden RAE. The macromolecular MR spectrum does not change with healthy aging. Magn Reson Med. 2021 Nov 28; doi: 10.1002/mrm.29093. Epub 2021 Nov 28. PMID: 34841564.
Copy Download .nbib Format: NLM
Age-group differences in instructed emotion regulation effectiveness: A systematic review and meta-analysis.

Psychology and aging

Mikkelsen MB, Tramm G, O'Toole MS.
PMID: 34472913
Psychol Aging. 2021 Dec;36(8):957-973. doi: 10.1037/pag0000627. Epub 2021 Sep 02.

Several theories of emotional development in adulthood provide the rationale for anticipating enhanced emotion regulation effectiveness (i.e., successful, goal-consistent regulation of emotions) with age. However, the existing empirical evidence is ambiguous. The aims of the present systematic review and...

Cite
Mikkelsen MB, Tramm G, O'Toole MS. Age-group differences in instructed emotion regulation effectiveness: A systematic review and meta-analysis. Psychol Aging. 2021;36(8):957-973doi: 10.1037/pag0000627.
Mikkelsen, M. B., Tramm, G., & O'Toole, M. S. (2021). Age-group differences in instructed emotion regulation effectiveness: A systematic review and meta-analysis. Psychology and aging, 36(8), 957-973. https://doi.org/10.1037/pag0000627
Mikkelsen, Mai Bjørnskov, et al. "Age-group differences in instructed emotion regulation effectiveness: A systematic review and meta-analysis." Psychology and aging vol. 36,8 (2021): 957-973. doi: https://doi.org/10.1037/pag0000627
Mikkelsen MB, Tramm G, O'Toole MS. Age-group differences in instructed emotion regulation effectiveness: A systematic review and meta-analysis. Psychol Aging. 2021 Dec;36(8):957-973. doi: 10.1037/pag0000627. Epub 2021 Sep 02. PMID: 34472913.
Copy Download .nbib Format: NLM
Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Mikkelsen MS, Petersen LK, Blaakaer J, Marinovskij E, Rosenkilde M, Andersen G, Bouchelouche K, Iversen LH.
PMID: 33812768
Eur J Surg Oncol. 2021 Aug;47(8):2134-2141. doi: 10.1016/j.ejso.2021.03.239. Epub 2021 Mar 16.

BACKGROUND: Preoperative assessment of peritoneal metastases is an important factor for treatment planning and selection of candidates for cytoreductive surgery (CRS) in primary advanced stage (FIGO stages III-IV) epithelial ovarian cancer (EOC). The primary aim was to evaluate the...

Cite
Mikkelsen MS, Petersen LK, Blaakaer J, et al. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer. Eur J Surg Oncol. 2021;47(8):2134-2141doi: 10.1016/j.ejso.2021.03.239.
Mikkelsen, M. S., Petersen, L. K., Blaakaer, J., Marinovskij, E., Rosenkilde, M., Andersen, G., Bouchelouche, K., & Iversen, L. H. (2021). Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 47(8), 2134-2141. https://doi.org/10.1016/j.ejso.2021.03.239
Mikkelsen, Mette Schou, et al. "Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 47,8 (2021): 2134-2141. doi: https://doi.org/10.1016/j.ejso.2021.03.239
Mikkelsen MS, Petersen LK, Blaakaer J, Marinovskij E, Rosenkilde M, Andersen G, Bouchelouche K, Iversen LH. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer. Eur J Surg Oncol. 2021 Aug;47(8):2134-2141. doi: 10.1016/j.ejso.2021.03.239. Epub 2021 Mar 16. PMID: 33812768.
Copy Download .nbib Format: NLM
Use of the Serious Illness Conversation Guide to Improve Communication with Surrogates of Critically Ill Patients. A Pilot Study.

ATS scholar

Pasricha V, Gorman D, Laothamatas K, Bhardwaj A, Ganta N, Mikkelsen ME.
PMID: 33870276
ATS Sch. 2020 Mar 18;1(2):119-133. doi: 10.34197/ats-scholar.2019-0006OC.

No abstract available.

Cite
Pasricha V, Gorman D, Laothamatas K, et al. Use of the Serious Illness Conversation Guide to Improve Communication with Surrogates of Critically Ill Patients. A Pilot Study. ATS Sch. 2020;1(2):119-133doi: 10.34197/ats-scholar.2019-0006OC.
Pasricha, V., Gorman, D., Laothamatas, K., Bhardwaj, A., Ganta, N., & Mikkelsen, M. E. (2020). Use of the Serious Illness Conversation Guide to Improve Communication with Surrogates of Critically Ill Patients. A Pilot Study. ATS scholar, 1(2), 119-133. https://doi.org/10.34197/ats-scholar.2019-0006OC
Pasricha, Venu, et al. "Use of the Serious Illness Conversation Guide to Improve Communication with Surrogates of Critically Ill Patients. A Pilot Study." ATS scholar vol. 1,2 (2020): 119-133. doi: https://doi.org/10.34197/ats-scholar.2019-0006OC
Pasricha V, Gorman D, Laothamatas K, Bhardwaj A, Ganta N, Mikkelsen ME. Use of the Serious Illness Conversation Guide to Improve Communication with Surrogates of Critically Ill Patients. A Pilot Study. ATS Sch. 2020 Mar 18;1(2):119-133. doi: 10.34197/ats-scholar.2019-0006OC. PMID: 33870276; PMCID: PMC8043290.
Copy Download .nbib Format: NLM
Electrorotation of particle-coated droplets: from fundamentals to applications.

Soft matter

Rozynek Z, Banaszak J, Mikkelsen A, Khobaib K, Magdziarz A.
PMID: 33908583
Soft Matter. 2021 Apr 28;17(16):4413-4425. doi: 10.1039/d1sm00122a.

Electrically insulating objects immersed in a weakly conducting liquid may Quincke rotate when subjected to an electric field. Experimental and theoretical investigations of this type of electrorotation typically concern rigid particles and particle-free droplets. This work provides the basic...

Cite
Rozynek Z, Banaszak J, Mikkelsen A, et al. Electrorotation of particle-coated droplets: from fundamentals to applications. Soft Matter. 2021;17(16):4413-4425doi: 10.1039/d1sm00122a.
Rozynek, Z., Banaszak, J., Mikkelsen, A., Khobaib, K., & Magdziarz, A. (2021). Electrorotation of particle-coated droplets: from fundamentals to applications. Soft matter, 17(16), 4413-4425. https://doi.org/10.1039/d1sm00122a
Rozynek, Z, et al. "Electrorotation of particle-coated droplets: from fundamentals to applications." Soft matter vol. 17,16 (2021): 4413-4425. doi: https://doi.org/10.1039/d1sm00122a
Rozynek Z, Banaszak J, Mikkelsen A, Khobaib K, Magdziarz A. Electrorotation of particle-coated droplets: from fundamentals to applications. Soft Matter. 2021 Apr 28;17(16):4413-4425. doi: 10.1039/d1sm00122a. PMID: 33908583.
Copy Download .nbib Format: NLM
Low-dose CT for diagnosing intestinal obstruction and pneumoperitoneum; need for retakes and diagnostic accuracy.

Acta radiologica open

Larsen NE, Mikkelsen E, Knudsen AR, Larsen LP.
PMID: 33786202
Acta Radiol Open. 2021 Mar 11;10(3):2058460121989313. doi: 10.1177/2058460121989313. eCollection 2021 Mar.

BACKGROUND: One of the main concerns using low-dose (LD) CT for evaluation of patients with suspected intestinal obstruction or pneumoperitoneum is the potential need to make an additional standard-dose (SD) CT scan (retake) due to insufficient diagnostic accuracy of...

Cite
Larsen NE, Mikkelsen E, Knudsen AR, et al. Low-dose CT for diagnosing intestinal obstruction and pneumoperitoneum; need for retakes and diagnostic accuracy. Acta Radiol Open. 2021;10(3):2058460121989313doi: 10.1177/2058460121989313.
Larsen, N. E., Mikkelsen, E., Knudsen, A. R., & Larsen, L. P. (2021). Low-dose CT for diagnosing intestinal obstruction and pneumoperitoneum; need for retakes and diagnostic accuracy. Acta radiologica open, 10(3), 2058460121989313. https://doi.org/10.1177/2058460121989313
Larsen, Nis E, et al. "Low-dose CT for diagnosing intestinal obstruction and pneumoperitoneum; need for retakes and diagnostic accuracy." Acta radiologica open vol. 10,3 (2021): 2058460121989313. doi: https://doi.org/10.1177/2058460121989313
Larsen NE, Mikkelsen E, Knudsen AR, Larsen LP. Low-dose CT for diagnosing intestinal obstruction and pneumoperitoneum; need for retakes and diagnostic accuracy. Acta Radiol Open. 2021 Mar 11;10(3):2058460121989313. doi: 10.1177/2058460121989313. eCollection 2021 Mar. PMID: 33786202; PMCID: PMC7958640.
Copy Download .nbib Format: NLM
Showing 361 to 372 of 372 entries